Dehydroindapamide is a structurally modified analog of the parent drug, featuring a chlorosulfonyl group conjugated to a pyridine ring via an oxazole bridge. Its core scaffold incorporates a 1,3-thiazine moiety with a para-chlorophenyl substituent, conferring enhanced lipophilicity. The dehydro prefix denotes an oxidized state relative to the parent compound, characterized by an additional carbonyl functionality at the indane backbone. This compound serves as a critical intermediate in the synthesis of sulfonamide-based diuretics, enabling regioselective functionalization of the aromatic heterocycle during API development.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| EP | I0150020 ↗ | 15 MG | EUR 90.00 |
| USP | 1338812 ↗ | 50 mg | USD 884.00 |
CC1=CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
InChI=1S/C16H14ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-9H,1H3,(H,19,21)(H2,18,22,23)
LWCDXWWLUHMMJI-UHFFFAOYSA-N